![T-knife Therapeutics bags $110M to sharpen solid tumor cell therapy push into the clinic | Fierce Biotech T-knife Therapeutics bags $110M to sharpen solid tumor cell therapy push into the clinic | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1627899641/Tom-Soloway_2-1.jpg?VersionId=k5zjWw0K3p0VabmFfw83Gv6yq9dcMvnJ)
T-knife Therapeutics bags $110M to sharpen solid tumor cell therapy push into the clinic | Fierce Biotech
![How ECCO's new Vitrus Mondial Collection Makes Formal Shoes Modern — And Comfortable - Sharp Magazine How ECCO's new Vitrus Mondial Collection Makes Formal Shoes Modern — And Comfortable - Sharp Magazine](https://sharpmagazine.com/wp-content/uploads/2020/05/HOM-2.jpg)
How ECCO's new Vitrus Mondial Collection Makes Formal Shoes Modern — And Comfortable - Sharp Magazine
![Sanofi hires ex-Roche executive John Reed to replace retiring Elias Zerhouni as R&D chief | Fierce Biotech Sanofi hires ex-Roche executive John Reed to replace retiring Elias Zerhouni as R&D chief | Fierce Biotech](https://qtxasset.com/quartz/qcloud5/media/image/fiercebiotech/1524558446/john-c-reed_740px.jpg/john-c-reed_740px.jpg?VersionId=IAWB_ZvluDlj1USLtNkoeNjgqvsv26AK)
Sanofi hires ex-Roche executive John Reed to replace retiring Elias Zerhouni as R&D chief | Fierce Biotech
![PDF) Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies PDF) Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies](https://i1.rgstatic.net/publication/333445914_Efficacy_and_Safety_of_Adalimumab_by_Disease_Duration_Analysis_of_Pooled_Data_From_Crohn's_Disease_Studies/links/5cf1cd6c4585153c3daa27a3/largepreview.png)